Bionovate Technologies (BIIO) Stock Statistics & Valuation Metrics
Total Valuation
Bionovate Technologies has a market cap or net worth of $775.00. The enterprise value is $238.16B.
- Market Cap
- $775.00
- Enterprise Value
- $238.16B
Share Statistics
Bionovate Technologies has 7,753,598 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 7,753,598
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bionovate Technologies’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 17.07%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 17.07%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Bionovate Technologies is -0.04. Bionovate Technologies’s PEG ratio is 0.00.
- PE Ratio
- -0.04
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -3.28
- Price to Operating Cash Flow
- -3.29
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Bionovate Technologies had revenue of 0 and earned -106.54K in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -45.37K
- Pretax Income
- -106.54K
- Net Income
- -106.54K
- EBITDA
- -240
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -236 and capital expenditures 0, giving a free cash flow of -236 billion.
- Operating Cash Flow
- -236
- Free Cash Flow
- -236
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Bionovate Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -30.45%
- Earnings Yield
- -13742.29%
Stock Price Statistics
- Beta
- 136.64
- 52-Week Price Change
- -99.31%
- 50-Day Moving Average
- 0.08
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Bionovate Technologies as a current ratio of 0.00, with Debt / Equity ratio of -47.17%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 32229.83
- Net Debt to EBITDA
- -5.23
- Interest Coverage Ratio
- -0.74
Taxes
In the past 12 months, Bionovate Technologies has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Bionovate Technologies EV to EBITDA ratio is -992.33, with an EV/FCF ratio of -1009.15.
- EV to Sales
- 0.00
- EV to EBITDA
- -992.33
- EV to Free Cash Flow
- -1009.15
- EV to Operating Cash Flow
- -1009.15
Balance Sheet
Bionovate Technologies has $0.00 in cash and marketable securities with $237.53K in debt, giving a net cash position of -$237.53K billion.
- Cash & Marketable Securities
- $0.00
- Total Debt
- $237.53K
- Net Cash
- -$237.53K
- Net Cash Per Share
- -$0.03
- Tangible Book Value Per Share
- -$0.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Bionovate Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
